510(k) K181663
K181663 is an FDA 510(k) premarket notification submitted by Genmark Diagnostics, Incorporated for the device "ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel". The FDA issued a decision of Substantially Equivalent on Dec 20, 2018. The device falls under product code PAM (Gram-Positive Bacteria And Their Resistance Markers), a Class II device regulated under 21 CFR 866.3365. Genmark Diagnostics, Incorporated has 6 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 20, 2018
- Date Received
- Jun 25, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Gram-Positive Bacteria And Their Resistance Markers
- Device Class
- Class II
- Regulation Number
- 866.3365
- Review Panel
- MI
- Submission Type
- 510(k)
A qualitive multiplexed in vitro diagnostic device to detect and identify Gram positive bacteria and resistant markers in positive blood cultures.
Need the full FDA record for Genmark Diagnostics, Incorporated? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.